Evidence map›Paper›PMID 23826280›Full record

SynthesisPloS one2013

Global Distribution of Campylobacter jejuni Penner Serotypes: A Systematic Review.

Brian L Pike, Patricia Guerry, Frédéric Poly

Registry-linked trialAbstract readSystematic Review
In one paragraph

Synthesis in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06122870 (Double-blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of CampETEC Hyperimmune Bovine Colostrum), which is not on this map. Cited by 26 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06122870 phase1completednot on this mapstarted 2023, after this paper: background citation

Double-blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of CampETEC Hyperimmune Bovine Colostrum (HBC) for the Prevention of Campylobacter-Mediated Diarrheal Diseases

TypeinterventionalSponsorJohns Hopkins Bloomberg School of Public HealthRan2023 to 2025Enrolled27ConditionsHealthy VolunteerArmsCampETEC HBC product, ProMilk 85, C. jejuni CG8421 Challenge strain
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Proteotyping ofMicroorganisms · 2023
    Article
  7. Article
  8. Microorganisms · 2022
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Zoonotic and Public Health Implications ofPathogens (Basel, Switzerland) · 2020
    Review
  14. Review
  15. Review
  16. Article
  17. Distribution of Capsular Types ofThe American journal of tropical medicine and hygiene · 2019
    Article
  18. Article
  19. Article
  20. Capsular genotype and lipooligosaccharide locus class distribution in Campylobacter jejuni from young children with diarrhea and asymptomatic carriers in Bangladesh.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Brian L PikeEnteric Diseases Department, Infectious Disease Directorate, Naval Medical Research Center, Silver Spring, Maryland, United States of America.
Patricia Guerry
Frédéric Poly

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Penner serotyping has been the principal method for differentiating Campylobacter isolates since its inception. Campylobacter capsule polysaccharide (CPS), the principal serodeterminant on which Penner serotyping is based, is presently of interest as a vaccine component. To determine the required valency of an effective CPS-based vaccine, a comprehensive understanding of CPS distribution is needed. Because of the association between Penner serotype and CPS, we conducted a systematic review to estimate the frequency and distribution of Penner serotypes associated with cases of Campylobacteriosis. In total, more than 21,000 sporadic cases of C. jejuni cases were identified for inclusion. While regional variation exists, distribution estimates indicate that eight serotypes accounted for more than half of all sporadic diarrheal cases globally and three serotypes (HS4 complex, HS2, and HS1/44) were dominant inter-regionally as well as globally. Furthermore, a total of 17 different serotypes reached a representation of 2% or greater in at least one of the five regions sampled. While this review is an important first step in defining CPS distribution, these results make it clear that significant gaps remain in our knowledge. Eliminating these gaps will be critical to future vaccine development efforts.

Indexed as

SerogroupAnimalsBacterial Typing TechniquesCampylobacter InfectionsCampylobacter jejuniGlobal HealthHumansPrevalence

Identifiers

PMID23826280
PMCPMC3694973

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.